Cardiac concentric hypertrophy promoted by activated Met receptor is mitigated in vivo by inhibition of Erk1,2 signalling with Pimasertib. (Q38790312)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on 25 February 2016

Language	Label	Description	Also known as
English	Cardiac concentric hypertrophy promoted by activated Met receptor is mitigated in vivo by inhibition of Erk1,2 signalling with Pimasertib.	scientific article published on 25 February 2016

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26924269%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Cardiac concentric hypertrophy promoted by activated Met receptor is mitigated in vivo by inhibition of Erk1,2 signalling with Pimasertib (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26924269%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Paolo M. Comoglio

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26924269%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26924269%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26924269%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26924269%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26924269%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Tiziana Crepaldi

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26924269%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

7

object named as

Lara Fontani

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26924269%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author name string

Stefano Gatti

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26924269%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Daniela Cantarella

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26924269%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Massimo Natale

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26924269%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Mara Morello

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26924269%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Antonio Ponzetto

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26924269%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

James Cimino

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26924269%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

publication date

26 February 2016

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26924269%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Journal of Molecular and Cellular Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26924269%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

93

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26924269%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

84-97

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26924269%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Heart disease and stroke statistics--2012 update: a report from the American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Genetic dissection of cardiac growth control pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Cardiac plasticity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Hypertrophic cardiomyopathy: from genetics to treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Signaling to cardiac hypertrophy: insights from human and mouse RASopathies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Clinical, pathological, and molecular analyses of cardiovascular abnormalities in Costello syndrome: a Ras/MAPK pathway syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Leopard syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

The cardiofaciocutaneous syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Noonan syndrome and clinically related disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

MET signalling: principles and functions in development, organ regeneration and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

From Tpr-Met to Met, tumorigenesis and tubes.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Enhanced expression of hepatocyte growth factor/c-Met by myocardial ischemia and reperfusion in a rat model

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

A potential cardioprotective role of hepatocyte growth factor in myocardial infarction in rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Involvement of receptor-type tyrosine kinase gene families in cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Aldosterone-Specific Activation of Cardiomyocyte Mineralocorticoid Receptor In Vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Gene transfection of hepatocyte growth factor attenuates the progression of cardiac remodeling in the hypertrophied heart.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Hepatocyte growth factor prevents tissue fibrosis, remodeling, and dysfunction in cardiomyopathic hamster hearts.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Activated Met signalling in the developing mouse heart leads to cardiac disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Increased circulating hepatocyte growth factor in the early stage of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

A multi-biomarker risk score improves prediction of long-term mortality in patients with advanced heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Hepatocyte growth factor is a strong predictor of mortality in patients with advanced heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Agonist antibodies activating the Met receptor protect cardiomyoblasts from cobalt chloride-induced apoptosis and autophagy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Agonist monoclonal antibodies against HGF receptor protect cardiac muscle cells from apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Novel therapy for myocardial infarction: can HGF/Met be beneficial?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Hepatocyte growth factor protects cardiac myocytes against oxidative stress-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Delivery of an engineered HGF fragment in an extracellular matrix-derived hydrogel prevents negative LV remodeling post-myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Hepatocyte growth factor/Met gene transfer in cardiac stem cells--potential for cardiac repair

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Hepatocyte growth factor regulates the TGF-β1-induced proliferation, differentiation and secretory function of cardiac fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Invasive growth: a MET-driven genetic programme for cancer and stem cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Targeting receptor tyrosine kinase MET in cancer: small molecule inhibitors and clinical progress

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Hypoxia-inducible factor-dependent degeneration, failure, and malignant transformation of the heart in the absence of the von Hippel-Lindau protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Effect of hepatocyte growth factor and angiotensin II on rat cardiomyocyte hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Global gene expression profiling in the failing myocardium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Gene expression signals involved in ischemic injury, extracellular matrix composition and fibrosis defined by global mRNA profiling of the human left ventricular myocardium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Conditional activation of MET in differentiated skeletal muscle induces atrophy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Gene expression profiling of HGF/Met activation in neonatal mouse heart

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Hemopexin therapy improves cardiovascular function by preventing heme-induced endothelial toxicity in mouse models of hemolytic diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Expander: from expression microarrays to networks and functions

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

GENECODIS: a web-based tool for finding significant concurrent annotations in gene lists

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

GeneCodis: interpreting gene lists through enrichment analysis and integration of diverse biological information

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

GeneCodis3: a non-redundant and modular enrichment analysis tool for functional genomics

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Functional analysis beyond enrichment: non-redundant reciprocal linkage of genes and biological terms.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

GeneMANIA Cytoscape plugin: fast gene function predictions on the desktop

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

DAVID: Database for Annotation, Visualization, and Integrated Discovery

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

oPOSSUM: identification of over-represented transcription factor binding sites in co-expressed genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

oPOSSUM: integrated tools for analysis of regulatory motif over-representation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Transcription factor regulation can be accurately predicted from the presence of target gene signatures in microarray gene expression data

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Tivantinib (ARQ197) displays cytotoxic activity that is independent of its ability to bind MET.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

ERK1/2 activation in heart is controlled by melusin, focal adhesion kinase and the scaffold protein IQGAP1

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Remodelling of gap junctions and connexin expression in diseased myocardium.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Hypertrophy of the heart: a new therapeutic target?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Regulation of cardiac hypertrophy by intracellular signalling pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1L613V mutation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

With great power comes great responsibility: using mouse genetics to study cardiac hypertrophy and failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Ventricular expression of a MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Targeted deletion of ERK2 in cardiomyocytes attenuates hypertrophic response but provokes pathological stress induced cardiac dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

DUSP6 (MKP3) null mice show enhanced ERK1/2 phosphorylation at baseline and increased myocyte proliferation in the heart affecting disease susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Genetic inhibition of cardiac ERK1/2 promotes stress-induced apoptosis and heart failure but has no effect on hypertrophy in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Cardiac natriuretic peptides: from basic discovery to clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

MEK1/2-ERK1/2 mediates alpha1-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Interleukin-18 induces EMMPRIN expression in primary cardiomyocytes via JNK/Sp1 signaling and MMP-9 in part via EMMPRIN and through AP-1 and NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Altered molecular response to adrenoreceptor-induced cardiac hypertrophy in Egr-1-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Oncostatin M stimulates tissue inhibitor of metalloproteinase-1 via a MEK-sensitive mechanism in human myofibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Glutathione suppresses TGF-beta-induced PAI-1 expression by inhibiting p38 and JNK MAPK and the binding of AP-1, SP-1, and Smad to the PAI-1 promoter

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

TIMPs as multifacial proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Gene expression profile in the early stage of angiotensin II-induced cardiac remodeling: a time series microarray study in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Genetic deficiency of plasminogen activator inhibitor-1 promotes cardiac fibrosis in aged mice: involvement of constitutive transforming growth factor-beta signaling and endothelial-to-mesenchymal transition.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

PAI-1 in tissue fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Myocardial Titin Hypophosphorylation Importantly Contributes to Heart Failure With Preserved Ejection Fraction in a Rat Metabolic Risk Model

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Myocardial Structure and Function Differ in Systolic and Diastolic Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 are increased in the coronary circulation in patients with acute coronary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Circulating biomarkers of collagen metabolism in arterial hypertension: relevance of target organ damage.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Plasminogen activator inhibitor-1: a common denominator in obesity, diabetes and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Biomarkers of heart failure with normal ejection fraction: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Hepatocyte growth factor (HGF) as a potential index of severity of hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

A novel vascular modulator, hepatocyte growth factor (HGF), as a potential index of the severity of hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Blockade of the MEK/ERK signalling cascade by AS703026, a novel selective MEK1/2 inhibitor, induces pleiotropic anti-myeloma activity in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Multikinase inhibitor sorafenib prevents pressure overload-induced left ventricular hypertrophy in rats by blocking the c-Raf/ERK1/2 signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2016.02.017

7 January 2021

Identifiers

10.1016/J.YJMCC.2016.02.017

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26924269%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26924269%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38790312&oldid=1744680977"